Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Capital Leases: 2018-2025

Historic Capital Leases for Neurogene (NGNE) over the last 6 years, with Sep 2025 value amounting to $7,000.

  • Neurogene's Capital Leases fell 82.05% to $7,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $7,000, marking a year-over-year decrease of 82.05%. This contributed to the annual value of $26,000 for FY2024, which is 60.00% down from last year.
  • Latest data reveals that Neurogene reported Capital Leases of $7,000 as of Q3 2025, which was down 22.22% from $9,000 recorded in Q2 2025.
  • In the past 5 years, Neurogene's Capital Leases ranged from a high of $65,000 in Q4 2023 and a low of $5,000 during Q3 2023.
  • In the last 3 years, Neurogene's Capital Leases had a median value of $17,000 in 2025 and averaged $26,091.
  • Its Capital Leases has fluctuated over the past 5 years, first skyrocketed by 783.33% in 2024, then slumped by 83.02% in 2025.
  • Over the past 3 years, Neurogene's Capital Leases (Quarterly) stood at $65,000 in 2023, then slumped by 60.00% to $26,000 in 2024, then plummeted by 82.05% to $7,000 in 2025.
  • Its last three reported values are $7,000 in Q3 2025, $9,000 for Q2 2025, and $17,000 during Q1 2025.